Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19218234 | 1.00 | PDK2 (0.38) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL19218247 | 0.95 | PDK2 (0.39) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL21141519 | 0.95 | PDK2 (0.35) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL19218360 | 0.95 | PDK2 (0.35) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL19218329 | 0.93 | MEN1 (0.39) | PDK2KDM4EMEN1LMNAMAPT | |
| SCHEMBL19218310 | 0.91 | PDK2 (0.36) | PDK2ESR1ESR2 | |
| SCHEMBL19218218 | 0.91 | PDK2 (0.38) | PDK2MEN1LMNAMAPTKMT2A | |
| SCHEMBL20218276 | 0.91 | PDK2 (0.36) | PDK2 | |
| SCHEMBL19218245 | 0.91 | PDK2 (0.35) | PDK2 | |
| SCHEMBL19218691 | 0.91 | PDK2 (0.38) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-20190296238-A1 | Organic Light-emitting Element | LG CHEM, LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
| US-10243148-B2 | Aromatic amine compound, and organic electroluminescent elements including the compound | IDEMITSU KOSAN CO., LTD. (JP) | 2019-03-26 | — | — | US | disclosed |
| US-20170229649-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170229649-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296238-A1 | Organic Light-emitting Element | CRY1, CRY2, NR2E3 | PDK2 3759/4885KDM4E 1903/4885MEN1 1414/4885 |
| US-10243148-B2 | Aromatic amine compound, and organic electroluminescent elements including the compound | H1-10, H1-0, H1-4 | PDK2 2391/4885KDM4E 942/4885MEN1 670/4885 |
| US-20170229649-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | L1CAM, LEF1, PIEZO1 | PDK2 2204/4885KDM4E 2978/4885MEN1 573/4885 |
| US-11877509-B2 | Organic light-emitting element | CRY1, CRY2, NR2E3 | PDK2 3759/4885KDM4E 1903/4885MEN1 1414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.